Search

Your search keyword '"Rohatgi, Nidhi"' showing total 257 results

Search Constraints

Start Over You searched for: Author "Rohatgi, Nidhi" Remove constraint Author: "Rohatgi, Nidhi"
257 results on '"Rohatgi, Nidhi"'

Search Results

1. Adapted Large Language Models Can Outperform Medical Experts in Clinical Text Summarization

2. Association between Obesity and Length of COVID-19 Hospitalization: Unexpected Insights from the American Heart Association National COVID-19 Registry

3. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

7. Contributors

9. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

11. Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity

13. Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure

15. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*

18. Adapted large language models can outperform medical experts in clinical text summarization

25. Clinical Text Summarization: Adapting Large Language Models Can Outperform Human Experts

28. Tmem178 Negatively Regulates IL‐1β Production Through Inhibition of the NLRP3 Inflammasome.

30. Tmem178 negatively regulates IL-1β production through inhibition of the NLRP3 inflammasome

36. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

37. Tocilizumab in patients hospitalised with COVID-19 pneumonia:Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

38. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial

42. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial

48. Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial

Catalog

Books, media, physical & digital resources